Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Clinical trials on a large scale and safety data collected after marketing have not shown proof that GLP-1 therapies cause lasting menstrual issues
Patients receive this blend through an infusion that sends these essential ingredients directly into the bloodstream, where it can quickly ease headaches, nausea, fatigue, and more
Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected
The insulin-sensitising effects of retatrutide are particularly relevant for PCOS
US$ 22.70
US$ 21.61
US$ 20.73
US$ 28.51
